anifrolumab - CISMeF

Preferred Label : anifrolumab;

MeSH note : in phase I clinical trials for treatment of systemic sclerosis; directed against type I IFN-alpha receptor;

CISMeF synonym : MEDI-546;

Is substance : O;

UNII : 38RL9AE51Q;

Details

Origin ID

C582345;

UMLS CUI

C4519739;

ATC code(s)
- anifrolumab [ATC Code]
Currated CISMeF NLP mapping
- Anifrolumab [NCIt concept]
- Anifrolumab [SMS substance]
MeSH term(s) associated for indexing
- antibodies, monoclonal [MeSH Descriptor]
- antibodies, monoclonal, humanized [MeSH Descriptor]
Record concept(s)
- MEDI-546 [MeSH concept]
- Saphnelo [MeSH concept]
- anifrolumab [MeSH concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Anifrolumab [NCIt concept]
- anifrolumab [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients